rs147462227
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_001083116.3(PRF1):c.445G>A(p.Gly149Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000675 in 1,614,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001083116.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251436Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135898
GnomAD4 exome AF: 0.0000670 AC: 98AN: 1461892Hom.: 0 Cov.: 34 AF XY: 0.0000715 AC XY: 52AN XY: 727246
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74486
ClinVar
Submissions by phenotype
Familial hemophagocytic lymphohistiocytosis 2 Pathogenic:3
- -
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 149 of the PRF1 protein (p.Gly149Ser). This variant is present in population databases (rs147462227, gnomAD 0.06%). This missense change has been observed in individual(s) with clinical features of hemophagocytic lymphohistiocytosis (PMID: 16278825, 17873118, 21959744, 26184781; externalcommunication). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 520942). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PRF1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects PRF1 function (PMID: 16374518). For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:2
Published functional studies demonstrate a damaging effect with reduced expression and absence of cytotoxic activity (PMID: 15755897); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21881043, 21959744, 24916509, 23073290, 17873118, 23592409, 19487666, 16374518, 11756153, 26184781, 16278825, 27577878, 33694335, 31589614, 34308104, 25297583, 32542393, 36440336, 36964991, 37365821, 15755897) -
PP3, PM3, PS3, PS4_moderate -
Aplastic anemia Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
- -
Familial hemophagocytic lymphohistiocytosis Pathogenic:1
Variant summary: PRF1 c.445G>A (p.Gly149Ser) results in a non-conservative amino acid change located in the membrane attack complex component/perforin (MACPF) domain (IPR020864) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00014 in 251436 control chromosomes, predominantly at a frequency of 0.00064 within the Latino subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in PRF1 causing Familial Hemophagocytic Lymphohistiocytosis (0.00014 vs 0.0027), allowing no conclusion about variant significance. c.445G>A has been reported in the literature as a biallelic genotype in multiple individuals affected with Familial Hemophagocytic Lymphohistiocytosis. These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function in vitro (e.g. Voskoboinik_2005). The variant had little to no detectable protein expression compared to WT perforin and had minimal detectable cytotoxic activity in a cell-based assay. The following publications have been ascertained in the context of this evaluation (PMID: 11756153, 14757862, 15755897, 17873118). Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Aplastic anemia;C1863727:Familial hemophagocytic lymphohistiocytosis 2;C4721532:Lymphoma, non-Hodgkin, familial Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at